A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 781 | 2016 |
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy A Kambugu, DB Meya, J Rhein, M O'Brien, EN Janoff, AR Ronald, ... Clinical infectious diseases 46 (11), 1694-1701, 2008 | 375 | 2008 |
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection JD Simmons, CM Stein, C Seshadri, M Campo, G Alter, S Fortune, ... Nature Reviews Immunology 18 (9), 575-589, 2018 | 290 | 2018 |
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis RS Wallis, P Kyambadde, JL Johnson, L Horter, R Kittle, M Pohle, ... Aids 18 (2), 257-264, 2004 | 273 | 2004 |
Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study MS Kiwuwa, K Charles, MK Harriet BMC public health 5, 1-7, 2005 | 271 | 2005 |
Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 268 | 2018 |
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients Z Toossi, H Mayanja-Kizza, CS Hirsch, KL Edmonds, T Spahlinger, ... Clinical & Experimental Immunology 123 (2), 233-238, 2001 | 263 | 2001 |
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy MR Kamya, H Mayanja-Kizza, A Kambugu, S Bakeera-Kitaka, F Semitala, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (2), 187-193, 2007 | 257 | 2007 |
IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure LL Lu, MT Smith, KKQ Yu, C Luedemann, TJ Suscovich, PS Grace, A Cain, ... Nature medicine 25 (6), 977-987, 2019 | 231 | 2019 |
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities DA Helb, KKA Tetteh, PL Felgner, J Skinner, A Hubbard, E Arinaitwe, ... Proceedings of the National Academy of Sciences 112 (32), E4438-E4447, 2015 | 224 | 2015 |
Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda AK Ziraba, J Bwogi, A Namale, CW Wainaina, H Mayanja-Kizza BMC infectious diseases 10, 1-12, 2010 | 209 | 2010 |
Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population ST Jacob, CC Moore, P Banura, R Pinkerton, D Meya, P Opendi, ... PloS one 4 (11), e7782, 2009 | 174 | 2009 |
Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and … NN Chegou, JS Sutherland, S Malherbe, AC Crampin, PLAM Corstjens, ... Thorax 71 (9), 785-794, 2016 | 172 | 2016 |
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda H Mayanja-Kizza, E Jones-Lopez, A Okwera, RS Wallis, JJ Ellner, ... The Journal of infectious diseases 191 (6), 856-865, 2005 | 164 | 2005 |
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS HM Kizza, K Oishi, S Mitarai, H Yamashita, K Nalongo, K Watanabe, ... Clinical infectious diseases 26 (6), 1362-1366, 1998 | 159 | 1998 |
FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure RT Sullivan, CC Kim, MF Fontana, ME Feeney, P Jagannathan, MJ Boyle, ... PLoS pathogens 11 (5), e1004894, 2015 | 154 | 2015 |
Genome scan of M. tuberculosis infection and disease in Ugandans CM Stein, S Zalwango, LSL Malone, S Won, H Mayanja-Kizza, ... PloS one 3 (12), e4094, 2008 | 149 | 2008 |
Concise gene signature for point‐of‐care classification of tuberculosis J Maertzdorf, G McEwen, J Weiner 3rd, S Tian, E Lader, U Schriek, ... EMBO molecular medicine 8 (2), 86-95, 2016 | 147 | 2016 |
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort D Nakanjako, I Ssewanyana, H Mayanja-Kizza, A Kiragga, ... BMC infectious diseases 11, 1-9, 2011 | 147 | 2011 |
The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study ST Jacob, P Banura, JM Baeten, CC Moore, D Meya, L Nakiyingi, R Burke, ... Critical care medicine 40 (7), 2050-2058, 2012 | 144 | 2012 |